San Diego-based AFYX Therapeutics, a clinical stage biopharmaceutical company, has secured $13 million in convertible loan financing. Sofinnova Ventures was the lead investor.
Source: Press Release
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: subscriptions@peimedia.com.-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: